|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody rituximab显示文摘 | SACCHI S FEDERICO M DASTOLI G | 2001 | Crit Rev Oncol Hematol2001，37，： | 1 |
| 2 | Treatment of B-cell non-Hodgkin’s lymphoma with anti CD 20 monoclonal antibody Rituximab显示文摘 | Stefano Sacchi Massimo Federico Giuseppe Dastoli Claudia Fiorani Giovanni Vinci Vera Clò Barbara Casolari | 2001 | Critical Reviews in Oncology and Hematology2001，，1： | 1 |
| 3 | Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: Evidence for a role of both chemotherapy and rituximab infusion 显示文摘 | Magni M Di Nicola M Devizzi L Matteucci P Lombardi F Gandola L Ravagnani F Giardini R Dastoli G Tarella C Pileri A Bonadonna G Gianni AM | 2000 | Blood2000，96，3： | 1 |
| 4 | Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyn- gioma 显示文摘 | Cavalheiro S Dastoli PA Silva NS | 2005 | Childs Nerv Syst2005，21，89： | 1 |
| 5 | Cystic craniopharyngioma:intratumoral chemotherapy with alpha interferon 显示文摘 | Dastoli PA Nicacio JM Silva NS | 2011 | Arq Neuropsiquiatr2011，69，1： | 1 |
| 6 | Treatment of B-cell nonHodgkin's lymphoma with CD20 monoclonal antibody rituximab显示文摘 | Sacchi S Federico M Dastoli G | | 0，，： | 1 |
| 7 | Treatment of anterior skull base defects by a transnasal endoscopic approach in children 显示文摘 | Di Rocco F Couloigner V Dastoli P | 2010 | Neurosurg Pediatr2010，6，4： | 1 |
| 8 | Treatment of B-cell nonHodgkin's lymphoma with anti CD20 monoclonal antibody Rituximab显示文摘 | Sacchi S Federico M Dastoli G | 2001 | Crit Rev Oncol Hemato2001，37，1： | 1 |
| 9 | Treatment of B-Cell nonHodgkins lymphoma with anti CD20 monoclonal antibody Rituximab显示文摘 | Sacchi S Federico M Dastoli G | 2001 | Crit Rev Oncol Hematol2001，37，1： | 1 |
| 10 | Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab显示文摘 | Sacchi S Federico M Dastoli G | 2001 | Crit Rev Oncol Hematol2001，37，： | 1 |
| 11 | Histopathology and immunophenotyping of late onset cutaneous manifestations of COVID-19 in elderly patients: Three case reports显示文摘BACKGROUND Several cutaneous manifestations such as urticarial rash,erythematous patches and chilblain-like lesions have been described in young adults with coronavirus disease 2019(COVID-19)and are present in up to 20%patients,but few reports exist describing histopathological and immunophenotypic characteristics of dermatological lesions in older patients.Our aim was to characterize skin lesions in elderly patients during late stages of COVID-19 from clinical,histological and immunophenotypic perspectives.CASE SUMMARY Three patients,admitted for COVID-19,and who developed cutaneous manifestations underwent skin biopsies.Immunophenotypic analysis for CD20,CD3,CD4 and CD8 was performed on skin biopsies to assess immune cell infiltrates.CD1a was used as a marker of Langerhans cells,and CD31 as a marker of endothelial cells.In the three study patients,cutaneous manifestations were evident in the late-stage of COVID-19(mean time from the first positive severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)swab to rash onset was 35 d).Skin biopsies showed a similar pattern of T lymphocyte infiltration in all patients.Indeed,a chronic dermatitis with perivascular lymphocytic infiltrate was observed with predominance of CD3+T-cell(CD3+).CONCLUSION Our study confirms previous reports.Histological and immunophenotypic patterns in our patients confirm results described in the two previous reported experiences.This pattern is similar to what is found in some lympho-proliferative disorders.Therefore,since these findings are non-specific,SARS-CoV-2 infection should be suspected. | Maria Mazzitelli Stefano Dastoli Chiara Mignogna Luigi Bennardo Elena Lio Maria Chiara Pelle Enrico Maria Trecarichi Branca Isabel Pereira Steven Paul Nisticò Carlo Torti | 2021 | World Journal of Clinical Cases2021，9，20： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员